We are monitoring the impact of COVID-19 on North America Colorectal Cancer Market Get in touch with us for detailed analysis Know More
Share on

North America Colorectal Cancer Market Research Report – Segmented By Diagnosis, Treatment, and country (United States, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast | 2022 to 2027

Published: January, 2022
ID: 565
Pages: 137

North America Colorectal Cancer Market Size (2022 to 2027)

The size of the Colorectal Cancer Market in North America was worth USD 4.57 billion in 2022. It is estimated to be growing at a CAGR of 2.21% and worth USD 5.10 billion by 2027.

Colorectal cancer results from unrestrained cell growth in the appendix, colon, and rectum region. Colorectal Cancer originates in the colon or the rectum. Due to the similar characteristics of colon cancer and rectum cancer, they are grouped. Colorectal Cancer begins as a growth on the inner lining of the colon or rectum, called polyps.

The North American colorectal cancer market is primarily forecasted to be driven by factors such as a surge in the pipeline colorectal cancer screening tests, an aging population, rising awareness, and government policies to deliver improved colorectal cancer care. Also, an increase in the prevalence of colorectal cancer year over year due to individuals' bad eating habits and irregular food intake timings are influencing the market growth. In addition, the overall demand for the North American colorectal cancer market is expected to rise as the senior population grows and the number of clinical trials to bring new medications to market grows.

On the other hand, with the rising frequency of colorectal cancer, new product introductions, and the benefits of generic drugs, the market for colorectal cancer is likely to expand. In addition, the expanding pharmaceutical industry in emerging economies is expected to boost the market growth in the future years.

Growing research and development spending for cancer research and increasing healthcare spending is expected to boost the growth of the North American colorectal cancer market. In addition, medical tourism in emerging areas and the rise of pharmaceuticals in the region are projected to increase the market and present considerable potential prospects.

However, the primary reason impeding the market’s growth is the high cost of screening tests.

This research report on the North American colorectal cancer market has been segmented and sub-segmented into the following categories:

By Diagnosis:

  • Digital Rectal Examination
  • Faecal Occult Blood Test
  • Flexible Sigmoidoscopy
  • Colonoscopy
  • Virtual Colonoscopy

By Treatment:

  • Surgery and Radiation Therapy
  • Chemotherapy
  • Targeted Therapies
  • Resistance to Pharmacological Therapies

By Country: 

  • The United States
  • Canada
  • Rest of North America

The North American colorectal cancer market held a share of 37% in the global market in 2020, and it is expected to continue to lead throughout the forecast period. The market in North America is relatively modern, with a focus on developing cost-effective procedures. In addition, companies are dedicated to research, sourcing, and quality, all of which are key to market success. 

In the North American regional market, with about 85%, the United States colorectal cancer market dominates. This is attributed to increasing consumer awareness of colorectal cancer diagnosis and treatment options. The condition is the second most cause of colorectal cancer treatments and medications, which has boosted the market growth in this region. In addition, new technical advancements, FDA approval of new pharmaceuticals, and the presence of essential competitors in the market are further contributing to the market expansion. Colorectal cancer is the third most common cancer in the United States, after skin cancer and lung cancer. According to the American Cancer Society, 104270 new instances of colon cancer and 45230 new cases of rectal cancer are being documented in the United States in 2022. 

On the other hand, the Canadian colorectal cancer market is expected to register a steady CAGR during the forecast period. According to the data given by the Canadian Cancer Society, approximately 1 in 14 Canadian men and 1 in 18 Canadian women will be diagnosed with colorectal cancer during their lifetime. As a result, the increased number of individuals with the disease is expected to fuel the growth of the North American colorectal cancer market during the forecast period.

KEY MARKET PLAYERS:

Companies playing a notable role in the North American colorectal cancer market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, and Vaccinogen BD.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Diagnosis                               

                                5.1.1 Digital Rectal Examination 

                                5.1.2 Faecal Occult Blood Test    

                                5.1.3 Flexible Sigmoidoscopy     

                                5.1.4 Colonoscopy          

                                5.1.5 Virtual Colonoscopy            

                5.2 By Treatment                            

                                5.2.1 Surgery and Radiation Therapy      

                                5.2.2 Chemotherapy      

                                5.2.3 Targeted Therapies             

                                5.2.4 Resistance to Pharmacological Therapies   

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Diagnostics                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Alere                             

                8.3 Beckman Coulter                     

                8.4 Clinical Genomics                     

                8.5 Companion Dx                          

                8.6 Hoffmann La Roche                

                8.7 Debiopharm Group                 

                8.8 Vaccinogen BD                          

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

11. Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Colorectal Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  2. North America Colorectal Cancer Market, By Diagnosis, From 2022 - 2027 (USD Billion)
  3. North America Digital Rectal Examination Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Faecal Occult Blood Test Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America Flexible Sigmoidoscopy Market, By Region, From 2022 - 2027 (USD Billion)
  6. North America Colonoscopy Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America Virtual Colonoscopy Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America Colorectal Cancer Market, By Treatment, From 2022 - 2027 (USD Billion)
  9. North America Surgery and Radiation Therapy Market, By Region, From 2022 - 2027 (USD Billion)
  10. North America Chemotherapy Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America Targeted Therapies Market, By Region, From 2022 - 2027 (USD Billion)
  12. North America Resistance to Pharmacological Therapies Market, By Region, From 2022 - 2027 (USD Billion)
  13. United States Colorectal Cancer Market, By Diagnosis, From 2022 - 2027 (USD Billion)
  14. United States Colorectal Cancer Market, By Treatment, From 2022 - 2027 (USD Billion)
  15. Canada Colorectal Cancer Market, By Diagnosis, From 2022 - 2027 (USD Billion)
  16. Canada Colorectal Cancer Market, By Treatment, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample